Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Integrated DNA Technologies (IDT) is a global leader in the development and manufacture of nucleic acid products for the life sciences industry. The company specializes in the synthesis of custom DNA and RNA oligonucleotides, which are essential tools for academic research, biotechnology, clinical diagnostics, and pharmaceutical development. IDT's product portfolio includes solutions for next-generation sequencing (NGS), CRISPR genome editing, synthetic biology, and qPCR. By providing high-quality synthetic nucleic acids, IDT enables breakthroughs in areas such as personalized medicine, agricultural biotechnology, and infectious disease research. The company is a key supplier to the global scientific community, supporting both basic research and the commercialization of molecular diagnostics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Innovative Design and Technology.